ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 735373 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 735373; 2) Community: the network communities that were significantly associated with the response to NSC 735373; 3) Molecule: the relationships between components within communities and NSC 735373; 4) MDR: the compounds that were significantly associated with the NSC 735373.

NSC Compound Enrichment Correlation
NSC 131233 Cyclopentanone, 2,5-bis[(dimethylamino)methyl]-, dihydrochloride 0.0342636096654271 0.27886448
NSC 176632 Stannane, trimethyl[(4-morpholinylthioxomethyl)thio]- 0.0342636096654271 0.39651206
NSC 251668 OVATIFOLIN ACETATE 0.0342636096654271 0.33671872
NSC 266047 1,2-Cyclohexanediamine, platinum complex, (1R-trans)- (9CI) 0.0342636096654271 0.32665189
NSC 338304 Iron, dichloro[hexahydro-1H-azepine-1-carbothioic acid [1-(2-pyridinyl)ethylidene]hydraziato] 0.0342636096654271 0.50363897
NSC 34533 Fulcin 0.0342636096654271 0.23618984
NSC 373355 Saframycin R 0.0342636096654271 0.27394111
NSC 381811 Poly(oxy-1,2-ethanediyl), .alpha.-methyl-.omega.-[[3- (5-fluoro-1,2,3,4-tetrahydro-2,4-dioxo-1-pyrimidinyl)- 1-oxopropyl]oxy]- 0.0342636096654271 0.068049899
NSC 45828 Purine, 2,6,8-tris(hexylamino)- 0.0342636096654271 0.47898197
NSC 529108 4-Fluoro-D,L-tryptophan 0.0342636096654271 0.14969134
Total:127  Current:87    [First] [Prev] [Next] [Last]